Summary of Purpose
The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 2 May 2013.
|1 Jul 2010||30 Apr 2013||1 Dec 2012||1 Dec 2012||1 Apr 2013||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case-Only
- Perspective: Prospective
- Sampling: Non-Probability Sample